Your body needs enough energy to work well
Tirzepatide weight loss shots have emerged as a highly effective treatment for obesity, but nausea remains the most common side effect patients experience
At The Beverly Hills MedSpa, we offer the latest advancements in medical weight loss, including Semaglutidean FDA-approved medication that is transforming the way people achieve sustainable results
[1] [2] Symptoms of gallbladder disease, including right upper quadrant pain, jaundice, or clay-colored stools, require assessment, as rapid weight loss increases cholelithiasis risk
Clinical trials capture adverse events under structured reporting but may undercount subjective complaints that patients do not report during visits
Sources Zepbound (tirzepatide) Injection, for subcutaneous use (2022) FDA Approves First Medication for Obstructive Sleep Apnea (December 20th, 2024) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (December 11, 2023)
